Grace H Tang, Rinku Sutradhar, Wing C Chan, Sumit Gupta, Monika Krzyzanowska, Petros Pechlivanoglou, Paul C Nathan
{"title":"Healthcare utilization among survivors of childhood and adolescent cancer: a population-based study.","authors":"Grace H Tang, Rinku Sutradhar, Wing C Chan, Sumit Gupta, Monika Krzyzanowska, Petros Pechlivanoglou, Paul C Nathan","doi":"10.1007/s11764-025-01863-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Survivors of childhood and adolescent cancers are at increased risk for late effects. Few studies have investigated if this translates into increased healthcare utilization during survivorship. We compared rates of healthcare utilization between survivors of childhood and adolescent cancer and matched cancer-free controls.</p><p><strong>Methods: </strong>This was a population-based matched cohort study using administrative databases in Ontario, Canada. The survivor cohort included individuals diagnosed with cancer ≤ 21 years old who had survived ≥ 5 years from their primary cancer diagnosis or relapse/recurrence during childhood/adolescence. Each survivor was matched to 5 controls based on year of birth, sex, and geographic location. Andersen-Gill recurrent event regression models were used to evaluate the association between survivorship and the rates of hospitalization, surgeries, diagnostic imaging, visits to the emergency department (ED), primary care physician (PCP), and sub-specialists. Models were adjusted for income quintile and comorbidity.</p><p><strong>Results: </strong>We identified 8090 survivors and 40,450 matched controls. Median follow-up time from index was 9 years. Compared to controls, survivors had higher rates of hospitalizations (adjusted relative rate (aRR) 1.82, 95% confidence interval [CI] 1.68-1.96), surgeries (aRR, 1.26; 95%CI, 1.20-1.32), sub-specialist visits (aRR, 1.55; 95%CI, 1.50-1.61), and diagnostic imaging (aRR, 1.48; 95%CI, 1.44-1.52). Rates of PCP and ED visits did not differ.</p><p><strong>Conclusions: </strong>Cancer survivors have higher rates of healthcare use compared to matched cancer-free controls in a publicly funded healthcare system.</p><p><strong>Implications for cancer survivors: </strong>Our findings suggest survivors do not receive additional care from their PCPs or visits to the ED. Future research is needed from other jurisdictions to supplement our findings.</p>","PeriodicalId":15284,"journal":{"name":"Journal of Cancer Survivorship","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Survivorship","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11764-025-01863-9","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Survivors of childhood and adolescent cancers are at increased risk for late effects. Few studies have investigated if this translates into increased healthcare utilization during survivorship. We compared rates of healthcare utilization between survivors of childhood and adolescent cancer and matched cancer-free controls.
Methods: This was a population-based matched cohort study using administrative databases in Ontario, Canada. The survivor cohort included individuals diagnosed with cancer ≤ 21 years old who had survived ≥ 5 years from their primary cancer diagnosis or relapse/recurrence during childhood/adolescence. Each survivor was matched to 5 controls based on year of birth, sex, and geographic location. Andersen-Gill recurrent event regression models were used to evaluate the association between survivorship and the rates of hospitalization, surgeries, diagnostic imaging, visits to the emergency department (ED), primary care physician (PCP), and sub-specialists. Models were adjusted for income quintile and comorbidity.
Results: We identified 8090 survivors and 40,450 matched controls. Median follow-up time from index was 9 years. Compared to controls, survivors had higher rates of hospitalizations (adjusted relative rate (aRR) 1.82, 95% confidence interval [CI] 1.68-1.96), surgeries (aRR, 1.26; 95%CI, 1.20-1.32), sub-specialist visits (aRR, 1.55; 95%CI, 1.50-1.61), and diagnostic imaging (aRR, 1.48; 95%CI, 1.44-1.52). Rates of PCP and ED visits did not differ.
Conclusions: Cancer survivors have higher rates of healthcare use compared to matched cancer-free controls in a publicly funded healthcare system.
Implications for cancer survivors: Our findings suggest survivors do not receive additional care from their PCPs or visits to the ED. Future research is needed from other jurisdictions to supplement our findings.
期刊介绍:
Cancer survivorship is a worldwide concern. The aim of this multidisciplinary journal is to provide a global forum for new knowledge related to cancer survivorship. The journal publishes peer-reviewed papers relevant to improving the understanding, prevention, and management of the multiple areas related to cancer survivorship that can affect quality of care, access to care, longevity, and quality of life. It is a forum for research on humans (both laboratory and clinical), clinical studies, systematic and meta-analytic literature reviews, policy studies, and in rare situations case studies as long as they provide a new observation that should be followed up on to improve outcomes related to cancer survivors. Published articles represent a broad range of fields including oncology, primary care, physical medicine and rehabilitation, many other medical and nursing specialties, nursing, health services research, physical and occupational therapy, public health, behavioral medicine, psychology, social work, evidence-based policy, health economics, biobehavioral mechanisms, and qualitative analyses. The journal focuses exclusively on adult cancer survivors, young adult cancer survivors, and childhood cancer survivors who are young adults. Submissions must target those diagnosed with and treated for cancer.